Pelvic lymph node dissection - limited, extended, or not at all!

7th February 2022

GU Cast is back after our summer break in Melbourne, with a cracking episode focussing on pelvic lymph node dissection in prostate cancer. Pelvic lymph node dissection (PLND) is a perennially contentious topic in urology, and we were delighted today to welcome Dr Karim Touijer, Attending Surgeon at Memorial Sloan Kettering in New York, to discuss the randomised controlled trial which he and his colleagues published recently. This paper was highlighted as "Paper of the Year" by European Urology Oncology - congratulations to Dr Touijer and colleagues! A huge trial, with about 1500 men being randomised to undergo limited or extended PLND, to determine if a more extended dissection improved biochemical recurrence-free survival.

We were also delighted to welcome Dr Wouter "Wally" Everaerts to discuss this topic. Wally is Consultant Urologist and Program Director at KU Leuven, one of Europe's top prostate cancer centres, with huge expertise in PLND. Wally is a Melbourne alumnus and it was great have him on GU Cast. We enjoyed talking surgery in depth today - more surgically oriented discussions coming this year!

Links:

Eur Urol Oncol paper
Dr Karim Touijer Twitter
Dr Wouter Everaerts Twitter

Or you can listen to the audio-only version here